Altogether, our findings demonstrate that GPR92, a GPCR expressed in IMs and highly modulated by a HFD, controls the chronic inflammatory pathways that drive the pathogenesis of obesity-related diabetes. The gene discussed is LPAR5; the disease is obesity due to melanocortin 4 receptor deficiency.